Most Recent
BlueScope Steel has raised concerns over the ACCC’s subpoenas to produce documents in its civil penalty proceedings against the steel company, saying it may significantly broaden the regulator's claims about which businesses are its competitors.
The Australian arm of Fuchs Lubricants has succeeded in invalidating two patents owned by Quakers Chemicals, with the Full Federal Court finding the inventions were not novel because Quakers had tested them in public prior to applying for registration with IP Australia.
Just hours before her deadline, Australia Post's board said Wednesday it would enter talks with ex-CEO Christine Holgate, but has asked that her demands be made public.
Members of the Binetter family have filed proceedings against the bankruptcy trustees for the estate of Emil Binetter, the late founder of juice company Nudie, seeking documents on settlements they have reached in cases over debts or losses claimed against the family.
A mid-trial settlement has been reached in a lawsuit brought by the liquidators of collapsed steel giant Arrium against 10 former company directors and officers for allegedly engaging in insolvent trading.
The owner of a Cairns tour company sentenced to 12 months' jail for contempt of court by Federal Circuit Court judge Salvatore Vasta is seeking $2 million in damages in a lawsuit against the judge.
The ACCC has secured a misuse of market power declaration against Tasmanian government-owned TasPorts in the regulator's first action under amended competition laws, but the ports company will not pay a penalty as part of an agreement to resolve the case.
A shareholder class action against Crown Resorts can access transcripts of interviews conducted by the Victorian gaming regulator with former top brass and two Crown employees who were arrested in China in 2016 as part of a crackdown on gambling
Generic drug company Pharmacor has fired back in a patent lawsuit by Novartis, filing a cross-claim seeking to invalidate the Swiss drug giant's patents for its blockbuster MS drug Gilenya.
K&L Gates has bolstered its Australian intellectual property team by nabbing a leading IP lawyer and partner from rival Herbert Smith Freehills.